"10.1371_journal.pone.0076641","plos one","2013-10-29T00:00:00Z","Rufayda Mruwat; Saul Yedgar; Iris Lavon; Amiram Ariel; Miron Krimsky; David Shoseyov","Department of Biochemistry, Hebrew University Medical School, Jerusalem, Israel; Department of Neurology, Hadassah University Hospital, Jerusalem, Israel; Department of Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel; Pediatric Department, Hadassah University Hospital, Jerusalem, Israel","Conceived and designed the experiments: RM SY IL AA MK DS. Performed the experiments: RM MK DS. Analyzed the data: RM SY IL AA DS. Contributed reagents/materials/analysis tools: IL AA MK DS. Wrote the paper: RM SY DS.","The study used a compound (PLA2 inhibitor) proprietary of Celsus Therapeutics Plc. S. Yedgar serves on the board of the company and has shares in it. All other authors have no competing interests. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Rufayda Mruwat","RM",6,FALSE,6,3,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
